Skip to content

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

ISSN 1557-1904

3 papers in the library · 11 citations · publishing 2008-2025

Papers

Sort Most recent Most cited

Sigma-1 Receptor Activation by Fluvoxamine Ameliorates ER Stress, Synaptic Dysfunction and Behavioral Deficits in a Ketamine Model of Schizophrenia.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology July 25, 2025 Mariam K Ahmed, Kareem Abdou, Weam W Ibrahim et al. 5 citations

Endoplasmic reticulum (ER) stress and misfolded proteins accumulation are recognized as central factors in the development of psychiatric disorders. This study evaluated the potential therapeutic effect of fluvoxamine, a potent sigma-1 receptor agonist in alleviating protein misfolding and the subsequent ER stress in ketamine-induced model of schizophrenia. NE100 hydrochloride, a sigma-1...

Inhibition of oxidative stress, neuroinflammatory cytokines, and protein expressions contributes to the antipsychotic effects of geraniol in mice with ketamine-induced schizophrenia.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology July 3, 2025 Christian I Uruaka, Benneth Ben-Azu, Noah A Omeiza et al. 6 citations

Imbalances in redox and neuroinflammation are believed to play a role in the complex causes of schizophrenia, a widespread mental disorder characterized by abnormal behaviour. In this regard, we investigated the effects of geraniol, a natural compound with various medicinal uses, on ketamine-induced schizophrenia-like behaviour, oxidative stress and neuroinflammation in mice. We conducted three...

The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology December 2008 Bryan K. Yamamoto, Jamie Raudensky

Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are amphetamine derivatives with high abuse liability. These amphetamine-related drugs of abuse mediate their effects through the acute activation of both dopaminergic and serotonergic neurons. Long-term abuse of these amphetamine derivatives, however, results in damage to both dopaminergic and serotonergic terminals...